Printer Friendly

Browse Regorafenib topic

Articles

1-73 out of 73 article(s)
Title Author Type Date Words
Deciphera presents nine month follow-up data from INVICTUS study at ESMO. Clinical report Sep 18, 2020 400
Tiziana Life Sciences lands US patent for liver cancer drug in combination with tyrosine kinase inhibitors. Aug 22, 2020 351
Tiziana Life Sciences lands US patent for liver cancer drug in combination with tyrosine kinase inhibitors. Aug 22, 2020 349
Tiziana Life Sciences Gets US Patent For Milciclib In Cancer. Aug 21, 2020 340
Zai Lab receives China NMPA acceptance of NDA submission of ripretinib. Jul 20, 2020 349
Deciphera presents new data from Phase 3 INVICTUS study of Qinlock. Jul 2, 2020 355
Expression Atlas of FGF and FGFR Genes in Pancancer Uncovered Predictive Biomarkers for Clinical Trials of Selective FGFR Inhibitors. Li, Yuan; Wu, Long; Tao, Weiping; Wu, Dawei; Ma, Fei; Li, Ning Jun 30, 2020 3664
Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity. Jia, Wentao; Wang, Lina Jun 30, 2020 11398
Health Canada's Authorizes Qinlock for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor. Jun 23, 2020 223
Deciphera announces Health Canada authorizes sale of Qinlock. Jun 22, 2020 268
Tiziana Life Sciences outlines a busy schedule for 2020. Jun 19, 2020 501
Tiziana Life Sciences outlines a busy schedule for 2020. Jun 19, 2020 499
The FDA approves Qinlock (ripretinib) tablets for fourth line treatment of advanced gastrointestinal stromal tumours. May 18, 2020 256
The FDA approves Qinlock (ripretinib) tablets for fourth line treatment of advanced gastrointestinal stromal tumours. May 18, 2020 260
US FDA approves Qinlock tablets for treatment of advanced gastrointestinal stromal tumour. May 18, 2020 163
US FDA approves Qinlock tablets for treatment of advanced gastrointestinal stromal tumour. May 18, 2020 159
Tiziana's Milciclib drug meets primary endpoint in Phase 2a trial in Hepatocellular Carcinoma. May 15, 2020 187
Tiziana Life delighted with data from liver cancer treatment trials in Italy. May 15, 2020 356
FDA approves Deciphera's fourth-line treatment of advanced GIST. May 15, 2020 207
Tiziana's Milciclib drug meets primary endpoint in Phase 2a trial in Hepatocellular Carcinoma. May 15, 2020 185
Tiziana Life delighted with data from liver cancer treatment trials in Italy. May 15, 2020 354
Tiziana Life Sciences has four submissions accepted to virtual ASCO event. May 12, 2020 443
Tiziana Life Sciences has four submissions accepted to virtual ASCO event. May 12, 2020 441
Blueprint Medicines announces results from the Phase 3 VOYAGER clinical trial. Financial report Apr 28, 2020 161
Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions. Kreidieh, Malek; Mukherji, Deborah; Temraz, Sally; Shamseddine, Ali Mar 1, 2020 20117
Kazia Therapeutics' glioblastoma drug to join pivotal international trial: Edison. Jan 25, 2020 589
Kazia Therapeutics' glioblastoma drug to join pivotal international trial: Edison. Jan 25, 2020 587
WNT7A Overexpression Inhibits Growth and Migration of Hepatocellular Carcinoma via the [beta]-Catenin Independent Pathway. Lan, Lihui; Wang, Wei; Huang, Yue; Zhao, Chenghai; Bu, Xianmin Dec 31, 2019 4482
Deciphera Pharmaceuticals Submits New Drug Application to US FDA for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors. Dec 17, 2019 700
Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma. Zhang, Jie; Song, Qianqian; Liu, Jinxia; Lu, Lina; Xu, Yuqing; Zheng, Wenjie Nov 30, 2019 6126
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1. Badalamenti, Giuseppe; Barraco, Nadia; Incorvaia, Lorena; Galvano, Antonio; Fanale, Daniele; Cabibi, Nov 30, 2019 4725
CytoDyn's lead drug leronlimab inhibits colon carcinoma metastases to liver and lung in preclinical studies. Nov 20, 2019 626
Raymond James still confident in Blueprint's avapritinib and ripretinib. Oct 28, 2019 186
Raymond James still confident in Blueprint's avapritinib, Deciphera's ripretinib. Oct 28, 2019 189
World Intrahepatic Cholangiocarcinoma (ICC) Pipeline Insight Report 2019. Report Oct 21, 2019 921
CytoDyn's triple-negative breast cancer drug leronlimab given to first patient in clinical trial. Oct 1, 2019 362
Changing patterns of upper gastrointestinal bleeding over 23 years in Turkey. Danis, Nilay; Tekin, Fatih; Akarca, Ulus Salih; Unal, Nalan Gulsen; Erdogan, Elvan Isik; Akat, Kivan Oct 1, 2019 3891
Changing patterns of upper gastrointestinal bleeding over 23 years in Turkey. Danis, Nilay; Tekin, Fatih; Akarca, Ulus Salih; Unal, Nalan Gulsen; Erdogan, Elvan Isik; Akat, Kivan Oct 1, 2019 3911
CytoDyn has multiple shots on goal with its flagship drug leronlimab as cure for HIV, various cancers. Sep 20, 2019 1278
Novel Cancer Immunotherapies and Antitumor Immunity. Zhao, Lei; Zhang, Jianjun; Xu, Liang; Abbas, Hussein A. Aug 31, 2019 624
Deciphera Pharmaceuticals Reports Positive Updated Phase 1 Data for Ripretinib in Gastrointestinal Stromal Tumors. Aug 14, 2019 684
Deciphera Soars On Positive Readouts For Gastrointestinal Tumor Drug. Aug 13, 2019 504
Deciphera announces top-line results from Phase 3 INVICTUS study. Clinical report Aug 13, 2019 395
Bayer--Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga[R] (regorafenib) and Opdivo[R] (nivolumab) as combination therapy in patients with colorectal cancer--18/7/2019. Jul 26, 2019 420
Bristol-Myers Squibb (NYSE:BMY) - Bayer, Bristol-Myers Squibb and Ono Pharmaceutical Enter Into a Clinical Collaboration Agreement to Investigate Stivarga[R] (regorafenib) and Opdivo[R] (nivolumab) as Combination Therapy in Patients With Metastatic Colorectal Cancer -- 18/7/2019. Jul 22, 2019 432
Bristol-Myers, Ono Pharmaceutical and Bayer partnering in cancer combination. Jul 18, 2019 129
Bristol-Myers, Bayer and Ono Pharmaceutical announce clinical collaboration. Jul 18, 2019 206
CStone treats first patient in China with avapritinib under global Phase III clinical trial in advanced GIST. Jul 10, 2019 267
CStone treats first patient in China with avapritinib under global Phase III clinical trial in advanced GIST. Jul 10, 2019 263
Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis. Zhou, Rui-sheng; Wang, Xiong-Wen; Sun, Qin-feng; Ye, Zeng Jie; Liu, Jian-wei; Zhou, Dai-Han; Tang, Y Jun 30, 2019 6611
Bayer--Regorafenib to be tested in brain cancer patients in multi-arm cooperation trial--19/6/2019. Jun 26, 2019 406
Iran Unveils 7 New Knowledge-Based Products. Jun 19, 2019 467
Iran Unveils 9 New Home-Made Hi-Tech Drugs. Jun 18, 2019 405
Iran Boasts 3.3% Rise in Medicine Production. Jun 6, 2019 518
A rare case of Wild-Type GIST of descending colon with GANT characteristics. Kalliouris, Dimitrios N.; Nikou, Efstathios; Zaravinos, Spiridon; Manesis, Konstantinos; Oikonomou, Letter to the editor Jun 1, 2019 1426
A rare case of Wild-Type GIST of descending colon with GANT characteristics. Kalliouris, Dimitrios N.; Nikou, Efstathios; Zaravinos, Spiridon; Manesis, Konstantinos; Oikonomou, Jun 1, 2019 1485
Iranian VP Underlines Extensive Plans to Confront US Sanctions. May 26, 2019 244
Iran Industrializes Home-Made Drug to Treat Liver Cancer. May 12, 2019 390
Iran Unveils 4 New Drugs for Treating Cancer, Diabetes. May 7, 2019 551
Iran Vows to Indigenize Sanctioned Medicine. May 7, 2019 661
Iran Develops Know-How for Production of 4 Vital Cancer, Diabetes Drugs. May 6, 2019 427
Spontaneous Regression of Hepatocellular Carcinoma and Review of Reports in the Published English Literature. Chohan, Moaz B.Y.; Taylor, Nick; Coffin, Carla; Burak, Kelly W.; Bathe, Oliver F. Apr 30, 2019 3703
Corrigendum to "Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models". Correction notice Apr 30, 2019 256
Remodelling and Improvements in Organoid Technology to Study Liver Carcinogenesis in a Dish. Tharehalli, Umesh; Svinarenko, Michael; Lechel, Andre Mar 31, 2019 5652
Daptomycin-Induced Posterior Reversible Encephalopathy Syndrome (PRES). De Zayas-Enriquez, A. Bitar; Soper, C. Mar 31, 2019 2001
Acute Right Lower Abdomen in a Patient with a History of Gastrointestinal Stromal Tumor. Bandyopadhyay, Dabanjan; Bonatti, Hugo J.R. Mar 31, 2019 1780
Treatment Outcomes of Metastatic Colorectal Cancer Patients Treated with Regorafenib as Third-Line Setting-A Multicenter Study/Ucuncu Basamakta Regorafenib ile Tedavi Edilen Metastatik Kolorektal Kanserli Hastalarin Sonuclari-Cok Merkezli Calisma. Sahin, Suleyman; Hacioglu, Muhammet Bekir Mar 1, 2019 3427
Intestinal perforation after regorafenib usage. Sana, Bans; Karakas, Serdar; Uylas, Ufuk; Aktas, Aydm; Dikilitas, Mustafa; Kayaalp, Cuneyt Letter to the editor Mar 1, 2018 1340
Role of ncRNAs in Hepatocellular Carcinoma. Tu, Kangsheng; Dong, Qiongzhu; Tao, Junyan Jan 1, 2018 728
Surgical Resection with Neoadjuvant Chemotherapy for Locoregionally Recurrent Appendiceal Cancer Invading the External Iliac Vessels. Takahashi, Jun; Tsujinaka, Shingo; Kakizawa, Nao; Takayama, Noriya; Machida, Erika; Iseya, Kazuki; H Jan 1, 2018 3525
Metastasis of Hepatocellular Carcinoma to the Esophagus: Case Report and Review. Harada, Jun-ichiro; Matsutani, Takeshi; Hagiwara, Nobutoshi; Kawano, Yoichi; Matsuda, Akihisa; Tania Jan 1, 2018 2606
Plexin C1 Marks Liver Cancer Cells with Epithelial Phenotype and Is Overexpressed in Hepatocellular Carcinoma. Odabas, Gorkem; Cetin, Metin; Turhal, Serdar; Baloglu, Huseyin; Sayan, A. Emre; Yagci, Tamer Jan 1, 2018 5289
Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma. Korhan, Peyda; Yilmaz, Yeliz; Bagirsakci, Ezgi; Gunec, Aycim; Topel, Hande; Carres, Brian I.; Atabey Jan 1, 2018 5723

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters